ProQR Therapeutics (PRQR) Total Debt Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - | 15.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.83% |
| Dec 31, 2024 | 6.03% |
| Dec 31, 2023 | -33.15% |
| Sep 30, 2023 | -34.56% |
| Jun 30, 2023 | -90.34% |
| Mar 31, 2023 | -90.27% |
| Dec 31, 2022 | -86.30% |
| Sep 30, 2022 | -76.71% |
| Jun 30, 2022 | 97.22% |
| Mar 31, 2022 | 216,181.09% |
| Dec 31, 2021 | 144.19% |
| Sep 30, 2021 | 6.66% |
| Jun 30, 2021 | 278.77% |
| Mar 31, 2021 | -99.86% |
| Dec 31, 2020 | 42.97% |
| Sep 30, 2020 | 65.57% |
| Jun 30, 2020 | -53.64% |
| Mar 31, 2020 | 13,424,476.76% |
| Dec 31, 2019 | 34.72% |
| Sep 30, 2019 | 158,965,826.80% |
| Jun 30, 2019 | 61.89% |
| Mar 31, 2019 | -98.47% |
| Dec 31, 2018 | 25.73% |
| Dec 31, 2017 | 38.66% |
| Dec 31, 2016 | 116,230.81% |
| Dec 31, 2015 | -99.85% |
| Dec 31, 2014 | 174.02% |